Johnson &amp; Johnson to acquire Guidant for $25.4 billion
521877
INDIANAPOLIS - New Jersey-based health care products giant Johnson &amp; Johnson is buying Guidant Corp., one of the world&#39;s top makers of cardiac devices, for about $25.4 billion in cash and stock.
32462
Johnson &amp; Johnson, the US medical and consumer goods group, is in advanced discussions to buy Guidant, a maker of medical devices, in a deal that could be worth about $24bn (Â£12bn).
661105
US health titan Johnson and Johnson has reached a deal to acquire US heart device manufacturer Guidant Corporation, in a stock-and-cash deal valued at $23.9 billion, based on $76 a share, the companies said in a statement early this morning.
199086
Johnson & Johnson has agreed to  buy Guidant Corp. for $25.4 billion in cash and stock, the  companies said on Wednesday, giving the healthcare products  maker a foothold in the fast-growing market for implantable  devices that regulate heartbeats.
237836
CHICAGO/PHILADELPHIA  - Health care and consumer  products maker Johnson & Johnson is in negotiations to acquire  medical-device maker Guidant Corp., sources familiar with the  situation said on Tuesday.
437703
Health care giant Johnson &amp; Johnson is reportedly in advanced negotiations to acquire medical device maker Guidant Corp. for more than $24 billion.
328860
Stocks to watch on Tuesday: JOHNSON &  JOHNSON JNJ.N, GUIDANT CORP. GDT.N
373656
Johnson &amp; Johnson said late Wednesday that it will buy Guidant Corp. for $23.9 billion in a cash-and-stock deal that had been rumored for weeks.
584943
Johnson & Johnson  has sued  Boston Scientific  and Abbott Laboratories Inc. ,  seeking at least $5.5 billion in damages related to J&J's  failed bid to acquire medical device maker Guidant Corp.
218540
Johnson &amp; Johnson is in advanced talks to acquire Guidant Corp. for more than $24 billion, according to a New York Times report.
470326
Johnson &amp; Johnson said late last night it will acquire Guidant for $23.9 billion, a move that will give the big drug maker a bigger share of the explosive market for heart devices.
169716
Johnson &amp; Johnson (JNJ:NYSE - news - research) said Wednesday night that it would acquire medical equipment maker Guidant (GDT:NYSE - news - research) for $23.9 billion in cash and stock.
718989
Johnson & Johnson aims to seal a  purchase of Guidant Corp. without immediately jettisoning the  medical device maker's stent operations, sources familiar with  the situation said on Thursday.
719489
Pfizer Inc. said on Monday it had  reached a definitive agreement to sell its consumer healthcare  business to Johnson &amp; Johnson for &#36;16.6 billion in cash.
148143
Johnson & Johnson JNJ.N has sued   Boston Scientific BSX.N and Abbott Laboratories Inc. ABT.N,   seeking at least $5.5 billion in damages related to J&J's   failed bid to acquire medical device maker Guidant Corp.
346636
Stocks to watch on Tuesday: JOHNSON & JOHNSON , GUIDANT CORP.
177578
Even as the ink dries on Johnson &amp; Johnson&#39;s agreement to buy Guidant Corp. for $25.4 billion, it remains on the hunt for other companies that could bolster